T2 Biosystems
TTOO
$5.64
Share price
0.00%
Change (1 day)
1,988.89%
Change (1 year)
Categories
T2 Biosystems (TTOO) - Cash on Hand
Cash on Hand as of December 2023 : $15.68 M
According to T2 Biosystems
's latest financial reports the company has $15.68 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
T2 Biosystems - Cash on Hand chart (from 2013 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $10.32 M | -67.96% |
| 2021-12-31 | $32.24 M | -23.58% |
| 2020-12-31 | $42.18 M | 282.39% |
| 2019-12-31 | $11.03 M | -78.28% |
| 2018-12-31 | $50.8 M | 21.55% |
| 2017-12-31 | $41.79 M | -43.12% |
| 2016-12-31 | $73.48 M | -0.24% |
| 2015-12-31 | $73.66 M | -0.25% |
| 2014-12-31 | $73.84 M | 144.55% |
| 2013-12-31 | $30.19 M | 211.03% |
| 2012-12-31 | $9.7 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Aldeyra Therapeutics
ALDX | $0.14 B | 810.34% | 🇺🇸 USA |
 CareDx CDNA | $0.23 B | 1,400.53% | 🇺🇸 USA |